Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details)

v3.22.1
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) - shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 3,459,984 1,846,277
Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 1,245,468
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 929,892 600,009
Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,530,092 800